Statins, antidiabetic medications and liver histology in patients with diabetes with non-alcoholic fatty liver disease. - Wikidata - wikimedia - TriplyDB

Statins, antidiabetic medications and liver histology in patients with diabetes with non-alcoholic fatty liver disease.

Statins, antidiabetic medications and liver histology in patients with diabetes with non-alcoholic fatty liver disease.

http://www.wikidata.org/entity/Q36818830

about

Type 2 Diabetes in Non-Alcoholic Fatty Liver Disease and Hepatitis C Virus Infection--Liver: The "Musketeer" in the Spotlight Immune Imbalances in Non-Alcoholic Fatty Liver Disease: From General Biomarkers and Neutrophils to Interleukin-17 Axis Activation and New Therapeutic Targets Fatty liver is associated with an increased risk of diabetes and cardiovascular disease - Evidence from three different disease models: NAFLD, HCV and HIV Metabolic effects of Crocus sativus and protective action against non-alcoholic fatty liver disease in diabetic rats Multimorbidity and polypharmacy in diabetic patients with NAFLD: Implications for disease severity and management.Therapeutic application of GPR119 ligands in metabolic disorders.The Role of Nuclear Receptors in the Pathophysiology, Natural Course, and Drug Treatment of NAFLD in Humans.Pharmacological management of nonalcoholic fatty liver disease in type 2 diabetes.Nonalcoholic fatty liver disease: Evolving paradigms.Liver Safety of Statins in Prediabetes or T2DM and Nonalcoholic Steatohepatitis: Post Hoc Analysis of a Randomized Trial.Nonalcoholic fatty liver disease and chronic vascular complications of diabetes mellitus.Actions of metformin and statins on lipid and glucose metabolism and possible benefit of combination therapy.

P2860

Q26752583-5CCBD028-CA48-4FC3-803E-1F8BDFE1F070 Q28079713-9D6368E3-9136-461A-AA5E-9C4D31F64CC6 Q28079826-6BC2AA4C-29B7-4D13-B135-CC0CD14E5B12 Q33685820-68A40DB8-F3A4-48B8-A0BB-FDC4E8E13D63 Q33879548-CF1F2766-87E9-480F-8E05-FA3A147D9416 Q38655382-8819EE8D-B23C-48DE-8AE0-A16644BD59FE Q38752520-D87144C3-4E7A-4881-BBD4-433830C2A14A Q39170225-D46D0374-4F13-4599-B74D-BF85A6E1DB7C Q42695154-404322EC-0CBA-470B-AEE1-1729A52B8480 Q47868469-77F5D13A-10D0-40F8-BDA8-812343E5B595 Q49501260-50948D8F-92B2-435F-AFAC-2F8D209C8D19 Q55516148-5D1A42E2-A37E-48BE-B3D7-35E87B719F91

P2860

Statins, antidiabetic medications and liver histology in patients with diabetes with non-alcoholic fatty liver disease.

http://www.wikidata.org/entity/Q36818830

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Statins, antidiabetic medicati ...... alcoholic fatty liver disease.

@ast

Statins, antidiabetic medicati ...... alcoholic fatty liver disease.

@en

type

label

Statins, antidiabetic medicati ...... alcoholic fatty liver disease.

@ast

Statins, antidiabetic medicati ...... alcoholic fatty liver disease.

@en

prefLabel

Statins, antidiabetic medicati ...... alcoholic fatty liver disease.

@ast

Statins, antidiabetic medicati ...... alcoholic fatty liver disease.

@en

P1433

Q36818830-9E390689-D903-4605-A3BB-6C1141CF3752

P1476

Q36818830-F79CDC13-DF60-4A23-8F8F-1AA553E7D9B4

P2093

Q36818830-0C5A61B3-A66D-458A-A66E-6B98CDDAADDC

Q36818830-33E743C7-7A52-4864-9DAC-358BEF2D5F09

Q36818830-93FAD808-DA2E-4B6B-BEDA-CAAB338AD115

Q36818830-9C49116B-7560-49D8-858F-D8E61A7834D9

Q36818830-AB05AE01-56F1-4482-A6F2-6BB830491F03

Q36818830-D1456DD6-181E-47C3-8ECE-59AEC7F74334

Q36818830-F92EA150-1FEF-4697-8267-5EC11699A867

P2860

Q36818830-064D9C88-386F-45A6-AF0E-63DC342854D9

Q36818830-0D40D7DE-286C-4852-AEB2-C8D3EDD576B9

Q36818830-15706163-2554-4594-BA63-66CFC2DBC158

Q36818830-1663E973-09D1-46BB-B095-6B308681293F

Q36818830-1D5131A2-9FB6-4186-AD43-5233193F26B2

Q36818830-26294216-9359-477A-85B0-EF7E69C3F532

Q36818830-27DF62E2-8107-4AB8-AD46-A795AC81CAC3

Q36818830-3385B5DD-CC2F-4B52-BC6E-14CEE0229375

Q36818830-33F876C4-DDBC-470C-AB32-127AFA4C2294

Q36818830-3CB004B3-BA3D-4052-BBD8-774EFA52C8BE

P304

Q36818830-BA83BA65-E71F-47EF-8005-891168C9FF58

P31

Q36818830-CBC85BC0-BD21-4175-9914-53E15D924337

P356

Q36818830-592A10CA-65E6-48F8-8E9A-550BD7157043

P433

Q36818830-5E8F0344-A69A-49FA-9848-E5B91F73BD0E

P478

Q36818830-EFFABAA6-96E0-4B35-BAE6-1772BADF2950

P50

Q36818830-14FF58C4-BD78-4944-ACCC-75B54A5EEEF3

Q36818830-71AD52F6-A80E-4A97-A633-BDC4C031964B

Q36818830-C74BC595-0051-4FC6-B8DA-23CCA8C6273B

Q36818830-EE90893B-80F4-47AC-B24E-E0584D2ACE2C

P577

Q36818830-9F5E42A6-E798-408A-8657-B98BF9858769

P698

Q36818830-2D964A60-EDB1-4CDE-A055-E73E6BC5EB7C

P932

Q36818830-DBA59673-E633-44EE-B8D7-4FD726F2F0A5

P356

BMJGAST-2015-000075

P1433

BMJ open gastroenterology

P1476

Statins, antidiabetic medicati ...... alcoholic fatty liver disease.

@en

P2093

Christine Poitou

http://www.w3.org/2001/XMLSchema#string

Frederic Charlotte

http://www.w3.org/2001/XMLSchema#string

Joan Tordjman

http://www.w3.org/2001/XMLSchema#string

Judith Aron-Wisnewsky

http://www.w3.org/2001/XMLSchema#string

LIDO study Group

http://www.w3.org/2001/XMLSchema#string

Raluca Pais

http://www.w3.org/2001/XMLSchema#string

Vlad Ratziu

http://www.w3.org/2001/XMLSchema#string

P2860

Diagnosis and Classification of Diabetes Mellitus

From NAFLD in clinical practice to answers from guidelines

The efficacy and safety of statins for the treatment of non-alcoholic fatty liver disease

Targeting the insulin-like growth factor pathway in hepatocellular carcinoma

Standards of medical care in diabetes--2014

Design and validation of a histological scoring system for nonalcoholic fatty liver disease

Association of diabetes duration and diabetes treatment with the risk of hepatocellular carcinoma.

Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; Internat

Prevalence of and risk factors for hepatic steatosis and nonalcoholic Fatty liver disease in people with type 2 diabetes: the Edinburgh Type 2 Diabetes Study

Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease.

P304

e000075

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/BMJGAST-2015-000075

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P50

Thierry Poynard

Fabio Nascimbeni

Karine Clément

P577

2016-03-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27110380

http://www.w3.org/2001/XMLSchema#string

P932

4838660

http://www.w3.org/2001/XMLSchema#string